1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models
Main Authors: | Elizabeth Gray, Priyanka Gupta, Weiping Zeng, Shyra Gardai, Kaleb Smith, Katie Snead, Adam Hill, Kellie Spahr, Alyson J Smith, Elizabeth Cummins, David Gruber, Michelle L Ulrich, Mallory Long, Katelyn Hinricher, Aditi Langalia, Patrick Burke, Peter Senter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1149 Sensitizing aggressive murine pancreatic cancer to immune checkpoint blockade using a tumor-targeted, STING agonist ‘payloaded’ antibody
by: Michael Curran, et al.
Published: (2023-11-01) -
The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma
by: Martina Kleber, et al.
Published: (2023-12-01) -
Multiple myeloma with t(11;14): impact of novel agents on outcome
by: Borja Puertas, et al.
Published: (2023-03-01) -
Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity
by: Alyson J. Smith, et al.
Published: (2023-11-01) -
The Research of UAV Payload Calculation and Payload Platform
by: DONG Yiwei, et al.
Published: (2021-08-01)